Cite

HARVARD Citation

    Mason, H. et al. (n.d.). Uptake and outcomes of adjuvant durvalumab following concurrent chemoradiotherapy in unresected stage 3 non-small-cell lung cancer. Lung cancer. pp. S41-. [Online]. 
  
Back to record